C-type natriuretic peptide (CNP): The cardiovascular system and beyond

被引:2
作者
Dickinson, Yasmin A. [1 ]
Moyes, Amie J. [1 ]
Hobbs, Adrian J. [1 ]
机构
[1] Queen Mary Univ London, William Harvey Res Inst, Fac Med & Dent, Barts & London, Charterhouse Sq, London EC1M 6BQ, England
基金
英国生物技术与生命科学研究理事会;
关键词
C -type natriuretic peptide; Natriuretic peptide receptor; Cyclic GMP; G -protein coupled receptor; Heart; Vasculature; Kidney; Metabolism; Central nervous system; RECEPTOR NPR-B; MESANGIAL CELL-PROLIFERATION; CONGESTIVE-HEART-FAILURE; FIBROBLAST-GROWTH-FACTOR; OF-FUNCTION MUTATION; GUANYLYL CYCLASE; CLEARANCE RECEPTOR; BLOOD-PRESSURE; SINOATRIAL NODE; MOUSE MODEL;
D O I
10.1016/j.pharmthera.2024.108708
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
C-type natriuretic peptide (CNP) represents the 'local' member of the natriuretic peptide family, functioning in an autocrine or paracrine capacity to modulate a hugely diverse portfolio of physiological processes. Whilst the bestcharacterised of these regulatory roles are in the cardiovascular system, akin to its predominantly endocrine siblings atrial (ANP) and brain (BNP) natriuretic peptides, CNP governs many additional, unrelated mechanisms including bone growth, gamete maturation, auditory processing, and neuronal integrity. Furthermore, there is currently great interest in mimicking the biological activity of CNP for therapeutic gain in many of these disparate organ systems. Herein, we provide an overview of the physiology, pathophysiology and pharmacology of CNP in both cardiovascular and non-cardiovascular settings. (c) 2024 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license (http://
引用
收藏
页数:18
相关论文
共 50 条
  • [41] Phase 1 safety, tolerability, pharmacokinetics and pharmacodynamics results of a long-acting C-type natriuretic peptide prodrug, TransCon CNP
    Breinholt, Vibeke Miller
    Mygind, Per Holse
    Christoffersen, Eva Dam
    Zhang, Ying
    Ota, Sho
    Charlton, R. Will
    Viuff, Dorthe
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (11) : 4763 - 4772
  • [42] Circulating C-Type Natriuretic Peptide and Its Relationship to Cardiovascular Disease in the General Population
    Sangaralingham, S. Jeson
    McKie, Paul M.
    Ichiki, Tomoko
    Scott, Christopher G.
    Heublein, Denise M.
    Chen, Horng H.
    Bailey, Kent R.
    Redfield, Margaret M.
    Rodeheffer, Richard J.
    Burnett, John C., Jr.
    HYPERTENSION, 2015, 65 (06) : 1187 - U91
  • [43] Reduced ability of C-type natriuretic peptide (CNP) to activate natriuretic peptide receptor B (NPR-B) causes dwarfism in lbab-/- mice
    Yoder, Andrea R.
    Kruse, Andrew C.
    Earhart, Cathleen A.
    Ohlendorf, Douglas H.
    Potter, Lincoln R.
    PEPTIDES, 2008, 29 (09) : 1575 - 1581
  • [44] PLASMA BRAIN NATRIURETIC PEPTIDE AND C-TYPE NATRIURETIC PEPTIDE IN ESSENTIAL-HYPERTENSION
    CHEUNG, BM
    BROWN, MJ
    JOURNAL OF HYPERTENSION, 1994, 12 (04) : 449 - 454
  • [45] Detection of C-type natriuretic peptide in fetal circulation
    Stepan, H
    Walther, D
    Faber, R
    Walther, T
    JOURNAL OF PERINATAL MEDICINE, 2000, 28 (02) : 118 - 121
  • [46] Detection of C-type natriuretic peptide in normal pregnancy
    Stepan, H
    Walther, T
    Walther, D
    Faber, R
    JOURNAL OF PERINATAL MEDICINE, 1998, 26 (01) : 56 - 58
  • [47] C-Type Natriuretic Peptide (CNP) Inhibition of Interferon--Mediated Gene Expression in Human Endothelial Cells In Vitro
    Day, Amy
    Jameson, Zoe
    Hyde, Carolyn
    Simbi, Bigboy
    Fowkes, Robert
    Lawson, Charlotte
    BIOSENSORS-BASEL, 2018, 8 (03):
  • [48] C-Type Natriuretic Peptide: What, Where and Why?
    Korostyshevskaya I.M.
    Maksimov V.F.
    Rudenko N.S.
    Neuroscience and Behavioral Physiology, 2016, 46 (8) : 888 - 894
  • [49] C-type natriuretic peptide in growth: A new paradigm
    Olney, Robert C.
    GROWTH HORMONE & IGF RESEARCH, 2006, 16 : S6 - S14
  • [50] Ocular hypotension induced by intravitreally injected c-type natriuretic peptide
    Takashima, Y
    Taniguchi, T
    Yoshida, M
    Haque, MSR
    Igaki, T
    Itoh, H
    Nakao, K
    Honda, Y
    Yoshimura, N
    EXPERIMENTAL EYE RESEARCH, 1998, 66 (01) : 89 - 96